Daiichi Sankyo and Ranbaxy laboratories today announced plans to introduce innovator products of Daiichi Sankyo in Mexico through the marketing division, which was created last year within Ranbaxy’s Mexican subsidiary.
“We are excited about bringing our innovative products to the patients and doctors in Mexico,” said Takashi Shoda, President and CEO of Daiichi Sankyo.
At BSE, the company’s stocks were trading at Rs 412.45 up 1.7 per cent from its previous close.
